黃連素聯(lián)合阿托伐他汀對急性腦梗死患者治療作用的研究
[Abstract]:Objective: to investigate the effect of berberine combined with Atto vastatin on serum inflammatory factor (MIF,IL-6,CRP) levels and short-term clinical prognosis in patients with acute cerebral infarction (ACI). Methods: 120 patients with ACI were randomly divided into two groups: combined group (n = 60) and Atto group (n = 60). Both groups were given ACI routine therapy. The combined group was treated with berberine (300 mg tid) Atto vastatin) (40 mg qd), Atto vastatin group) and only Atto vastatin group (40 mg qd).) The serum MIF,IL-6,CRP level (14 days after admission) and neurological impairment score (1490 days after admission) were measured in all patients. Results: the serum MIF,IL-6,CRP level was positively correlated with the NIHSS score on the 1st and 14th day after admission (P0.05). On the first day of admission, there was no significant difference in MIF,IL-6,CRP level and NIHSS score between the two groups (P0.05). On the 14th day after admission, the serum MIF,IL-6,CRP level and NIHSS score of the two groups were significantly lower than that on the first day (P0.05). On the 14th day after admission, the serum MIF,IL-6,CRP level and NIHSS score in the combined group were significantly lower than those in the Atto vastatin group (P0.05). On the 90th day of follow-up, the m RS score of the combined group was significantly lower than that of the Atto vastatin group (P0.05), and the short-term good prognosis rate was significantly higher (P0.05). Conclusion: in the treatment of acute cerebral infarction, berberine combined with Atto vastatin can significantly reduce the level of serum inflammatory factor MIF,IL-6,CRP in acute phase of ACI, promote the recovery of nerve function and improve the short-term prognosis.
【作者單位】: 保定市第一中心醫(yī)院神經(jīng)內(nèi)三科;
【基金】:保定市科技局技術(shù)支撐項目(zf15015)
【分類號】:R743.33
【相似文獻】
相關(guān)期刊論文 前10條
1 李桂英,孟秋云;欣坦治療急性腦梗死42例療效觀察[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2002年07期
2 馬可夫,楮曉凡;急性腦梗死患者血清血管內(nèi)皮生長因子的測定[J];中風(fēng)與神經(jīng)疾病雜志;2003年01期
3 鄭曉紅;硫酸鎂佐治急性腦梗死40例療效觀察[J];臨床醫(yī)藥實踐;2003年09期
4 郭百海;周麗;;經(jīng)顱超聲多普勒診斷急性腦梗死的價值[J];中國實用內(nèi)科雜志;2006年S2期
5 翁;;;超敏C-反應(yīng)蛋白與急性腦梗死的相關(guān)性分析[J];廣西醫(yī)科大學(xué)學(xué)報;2007年01期
6 薛新宏;王大力;彭延波;張江;高素玲;常莉莎;張麗;趙曉晶;;急性腦梗死患者血清神經(jīng)元特異性烯醇化酶的變化[J];華北煤炭醫(yī)學(xué)院學(xué)報;2007年06期
7 郭秀鳳;李運剛;李化勇;夏英凱;;急性腦梗死患者血漿單核細胞趨化蛋白-1和組織因子的變化[J];中華老年心腦血管病雜志;2008年10期
8 馬莉莎;劉仲華;隋彩珍;;單唾液酸四己糖神經(jīng)節(jié)苷脂治療急性腦梗死64例療效觀察[J];山東醫(yī)藥;2009年05期
9 王永萍;;高同型半胱氨酸血癥與急性腦梗死關(guān)系探討[J];社區(qū)醫(yī)學(xué)雜志;2009年17期
10 趙學(xué)社;;68例急性腦梗死患者臨床檢測分析[J];中國現(xiàn)代藥物應(yīng)用;2010年09期
相關(guān)會議論文 前10條
1 黃菊明;;探討神經(jīng)元特異性烯醇化酶在急性腦梗死患者中的臨床價值[A];2007年浙江省神經(jīng)病學(xué)學(xué)術(shù)年會論文匯編[C];2007年
2 張允嶺;;急性腦梗死毒損腦絡(luò)學(xué)說基礎(chǔ)與臨床研究進展[A];第二屆中西醫(yī)結(jié)合腦病診治新進展高級研討班專家講義及論文匯編[C];2010年
3 毛銳;聶志余;靳令經(jīng);封亮;陳玉輝;李云霞;;頸動脈粥樣硬化性狹窄或閉塞所致急性腦梗死類型研究[A];中華醫(yī)學(xué)會第十三次全國神經(jīng)病學(xué)學(xué)術(shù)會議論文匯編[C];2010年
4 張小雨;張鳳;王棟;張媛媛;李曉紅;;急性腦梗死后血糖水平與輕度認知功能損害關(guān)系研究[A];2011全國老年癡呆與衰老相關(guān)疾病學(xué)術(shù)會議第三屆山東省神經(jīng)內(nèi)科醫(yī)師(學(xué)術(shù))論壇論文匯編[C];2011年
5 耿亞蘭;鐘傳林;楊清樺;;急性腦梗死患者超敏C-反應(yīng)蛋白監(jiān)測的臨床意義[A];貴州省醫(yī)學(xué)會第八屆神經(jīng)病學(xué)年會論文集[C];2010年
6 趙路清;崔愛勤;劉錦峰;張運生;王惠聰;郭學(xué)英;劉改生;郭志昌;;不同劑量金爾倫治療急性腦梗死的臨床研究[A];中華醫(yī)學(xué)會第七次全國神經(jīng)病學(xué)學(xué)術(shù)會議論文匯編[C];2004年
7 吳云成;趙永波;談永基;喬健;呂傳真;;血清神經(jīng)元特異性烯醇化酶與急性腦梗死患者遠期預(yù)后的相關(guān)性研究[A];中華醫(yī)學(xué)會第七次全國神經(jīng)病學(xué)學(xué)術(shù)會議論文匯編[C];2004年
8 劉軍;富昭;魚博浪;張明;丁暉;吳蘭琴;邵瑩;劉慶祿;;氫質(zhì)子磁共振波譜在急性腦梗死診斷中的價值[A];人體斷面數(shù)據(jù)獲取與圖像處理研討會論文匯編[C];2005年
9 蘇慶杰;陳志斌;蔡美華;王W,
本文編號:2373745
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2373745.html